Clean Science & Technology Ltd
Incorporated in 2003, Clean Science and Technology Ltd is one of the leading chemical manufacturers globally. It manufactures functionally critical specialty chemicals such as Performance Chemicals (MEHQ, BHA, and AP), Pharmaceutical Intermediates (Guaiacol and DCC), and FMCG Chemicals (4-MAP and Anisole). [1]
- Market Cap ₹ 12,488 Cr.
- Current Price ₹ 1,174
- High / Low ₹ 1,644 / 1,062
- Stock P/E 42.1
- Book Value ₹ 137
- Dividend Yield 0.51 %
- ROCE 29.3 %
- ROE 21.9 %
- Face Value ₹ 1.00
Pros
- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 25.1%
- Company has been maintaining a healthy dividend payout of 20.3%
Cons
- Stock is trading at 8.56 times its book value
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Part of BSE 500 Nifty 500 BSE MidCap BSE Allcap BSE Commodities
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
164 | 140 | 191 | 241 | 393 | 419 | 512 | 685 | 936 | 789 | 922 | 925 | |
106 | 92 | 118 | 168 | 256 | 234 | 253 | 385 | 533 | 452 | 523 | 523 | |
Operating Profit | 58 | 48 | 72 | 73 | 137 | 186 | 260 | 300 | 403 | 338 | 400 | 402 |
OPM % | 35% | 34% | 38% | 30% | 35% | 44% | 51% | 44% | 43% | 43% | 43% | 43% |
3 | 2 | 4 | 5 | 11 | 11 | 25 | 30 | 39 | 38 | 36 | 39 | |
Interest | 3 | 3 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 |
Depreciation | 5 | 6 | 6 | 8 | 11 | 14 | 17 | 25 | 36 | 44 | 44 | 44 |
Profit before tax | 53 | 41 | 70 | 70 | 137 | 182 | 267 | 305 | 405 | 331 | 391 | 397 |
Tax % | 34% | 34% | 33% | 30% | 28% | 23% | 26% | 25% | 25% | 25% | 25% | |
35 | 27 | 47 | 49 | 98 | 140 | 198 | 229 | 304 | 248 | 292 | 297 | |
EPS in Rs | 247.58 | 192.41 | 330.79 | 343.72 | 690.82 | 1,051.82 | 18.68 | 21.52 | 28.57 | 23.31 | 27.51 | 27.93 |
Dividend Payout % | 10% | 13% | 12% | 12% | 15% | 2% | 134% | 15% | 18% | 21% | 22% |
Compounded Sales Growth | |
---|---|
10 Years: | 19% |
5 Years: | 17% |
3 Years: | 10% |
TTM: | 13% |
Compounded Profit Growth | |
---|---|
10 Years: | 24% |
5 Years: | 16% |
3 Years: | 9% |
TTM: | 14% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | -13% |
1 Year: | -21% |
Return on Equity | |
---|---|
10 Years: | 30% |
5 Years: | 29% |
3 Years: | 25% |
Last Year: | 22% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 1 | 1 | 1 | 1 | 1 | 1 | 11 | 11 | 11 | 11 | 11 |
Reserves | 76 | 99 | 143 | 186 | 271 | 341 | 529 | 758 | 1,008 | 1,205 | 1,446 |
20 | 12 | 0 | 1 | 3 | 3 | 0 | 0 | 1 | 1 | 1 | |
29 | 27 | 35 | 48 | 53 | 85 | 120 | 156 | 139 | 154 | 147 | |
Total Liabilities | 127 | 139 | 179 | 236 | 328 | 430 | 660 | 925 | 1,159 | 1,371 | 1,605 |
60 | 64 | 77 | 101 | 126 | 166 | 186 | 296 | 427 | 401 | 364 | |
CWIP | 0 | 0 | 2 | 1 | 4 | 3 | 55 | 44 | 4 | 2 | 4 |
Investments | 1 | 1 | 32 | 18 | 76 | 134 | 233 | 247 | 428 | 666 | 907 |
65 | 75 | 68 | 115 | 122 | 127 | 187 | 338 | 300 | 302 | 330 | |
Total Assets | 127 | 139 | 179 | 236 | 328 | 430 | 660 | 925 | 1,159 | 1,371 | 1,605 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|
69 | 45 | 85 | 160 | 193 | 127 | 299 | 277 | 279 | |||
-52 | -17 | -94 | -106 | -186 | -124 | -245 | -228 | -221 | |||
-15 | -5 | -11 | -55 | -6 | -0 | -55 | -53 | -52 | |||
Net Cash Flow | 2 | 23 | -20 | -1 | 1 | 4 | -0 | -3 | 6 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 36 | 68 | 41 | 60 | 55 | 61 | 53 | 82 | 58 | 75 | 73 |
Inventory Days | 202 | 246 | 165 | 93 | 79 | 98 | 156 | 143 | 122 | 146 | 118 |
Days Payable | 71 | 79 | 73 | 85 | 48 | 101 | 180 | 166 | 90 | 121 | 83 |
Cash Conversion Cycle | 166 | 235 | 134 | 69 | 87 | 58 | 29 | 59 | 89 | 100 | 108 |
Working Capital Days | 87 | 131 | 64 | 61 | 62 | 33 | 32 | 90 | 66 | 78 | 79 |
ROCE % | 42% | 55% | 42% | 59% | 59% | 61% | 47% | 45% | 29% | 29% |
Documents
Announcements
-
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
25 Aug - Promoters sold 25,500,480 shares (24%) on Aug 21, 2025; holding fell to 54,162,845 (50.97%).
-
Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011 (SAST) In Respect Of Sale Of Equity Shares Of Clean Science And Technology Limited.
25 Aug - Promoters sold 2,55,00,480 shares (~24%) on Aug 21, 2025; holding reduced to ~51%.
-
Announcement under Regulation 30 (LODR)-Credit Rating
25 Aug - CRISIL reaffirmed Clean Science long-term CRISIL AA-/Stable and short-term A1+ on 25 Aug 2025.
-
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
22 Aug - Allotment of 6,532 Equity shares under CSTL ESOS 2021 of the Company.
-
Rumour verification - Regulation 30(11)
21 Aug - Promoters attempted up to ~24% sale; broker SIEPL executed erroneous larger sell orders; remedial steps underway (Aug 21, 2025)
Annual reports
Concalls
-
Jul 2025Transcript PPT REC
-
May 2025Transcript PPT REC
-
Feb 2025Transcript PPT REC
-
Nov 2024Transcript PPT REC
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT REC
-
Feb 2024Transcript PPT REC
-
Jan 2024TranscriptNotesPPTREC
-
Nov 2023Transcript PPT REC
-
Aug 2023Transcript PPT REC
-
May 2023Transcript PPT REC
-
Feb 2023Transcript PPT REC
-
Oct 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Jun 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Nov 2021Transcript PPT
-
Aug 2021Transcript PPT
Product Segment [1]
1) Performance Chemicals (69% in FY25 vs 69% in FY22): It manufactures Monomethyl Ether of Hydroquinone (MEHQ), used as a polymerization inhibitor in acrylic acids, acrylic esters, super absorbent polymers (diapers and sanitary pads), Butylated Hydroxy Anisole (BHA), used as anti-oxidant in food and feed industry, Ascorbyl Palmitate (AP), used in infant food formulations, breakfast cereals, and cosmetics, Tertiary Butyl Hydroquinone (TBHQ) used as a stabilizer in the oil industry and Hindered Amine light Stabilizers (HALS), used in water treatment and UV stabilization in a variety of polymers. TBHQ ranks 2nd globally, while the rest of the products are ranked no.1.